SCHEMBL5111850

SCHEMBL5111850

NC1C(=S)C(O)=Cc2ccccc21

nearest known ligand 0.33

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 1/20 0.33
GAA P10253 1/20 0.33
KMT2A Q03164 1/20 0.33
HTR2A P28223 2/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15064967 0.81
SCHEMBL15065612 0.77
SCHEMBL15065723 0.77
SCHEMBL17343612 0.75 MEN1 (0.38) MEN1GAAKMT2AHTR2A
SCHEMBL30181026 0.75 MEN1 (0.38) MEN1GAAKMT2AHTR2A
SCHEMBL680551 0.75 MEN1 (0.38) MEN1GAAKMT2AHTR2A
SCHEMBL680550 0.75 MEN1 (0.38) MEN1GAAKMT2AHTR2A
SCHEMBL15065080 0.73 LMNA (0.35)
SCHEMBL30272955 0.72 MEN1 (0.35) MEN1GAAKMT2AHTR2A
SCHEMBL15065155 0.72 ALDH1A1 (0.34)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7375225-B2 4-cyanocoumarin derivatives and uses thereof KABUSHIKI KAISHA HAYASHIBARA SEIBUTSU KAGAKU KENKYUJO (JP) 2008-05-20 US disclosed
CN-1826385-A Monoazo compound and method for producing same UENO SEIYAKU OYO KENKYUJO KK (JP) 2006-08-30 CN disclosed
US-20030176520-A1 4-cyanocoumarin derivatives and uses thereof KABUSHIKI KAISHA HAYASHIBARA SEIBUTSU KAGAKU KENKYUJO (JP) 2003-09-18 US disclosed
US-6573380-B2 Useful in photochemical polymerization, dye lasers, and electroluminescent elements KABUSHIKI KAISHA HAYASHIBARA SEIBUTSU KAGAKU KENKYUJO (JP) 2003-06-03 US disclosed
US-20020052501-A1 4-cyanocoumarin derivatives and uses thereof KABUSHIKI KAISHA HAYASHIBARA SEIBUTSU KAGAKU KENKYUJO (JP) 2002-05-02 US disclosed
EP-1041074-A1 Light-sensitive 4-cyanocoumarin derivatives KABUSHIKI KAISHA HAYASHIBARA SEIBUTSU KAGAKU KENKYUJO (JP) 2000-10-04 EP disclosed
CN-1006386-B PROCESS FOR PRODUCTION OF VINYL CHLORIDE POLYMER SHINETSU CHEM IND CO (JP) 1990-01-10 CN disclosed
CN-85107531-A Process for producing vinyl chloride polymer 1987-01-21 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030176520-A1 4-cyanocoumarin derivatives and uses thereof CACYBP, CYBA, IK MEN1 3808/4885GAA 1699/4885KMT2A 4278/4885
US-20020052501-A1 4-cyanocoumarin derivatives and uses thereof CACYBP, CYBA, IK MEN1 3808/4885GAA 1699/4885KMT2A 4278/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.